XTX Topco’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.41M Buy
+60,352
New +$8.45M 0.15% 91
2025
Q2
Sell
-9,156
Closed -$1.03M 2654
2025
Q1
$1.03M Buy
9,156
+3,976
+77% +$410K 0.05% 550
2024
Q4
$478K Sell
5,180
-1,744
-25% -$157K 0.04% 799
2024
Q3
$581K Buy
+6,924
New +$528K 0.04% 718
2024
Q2
Sell
-11,426
Closed -$837K 2081
2024
Q1
$837K Buy
+11,426
New +$879K 0.11% 226
2023
Q4
Sell
-8,070
Closed -$605K 1771
2023
Q3
$605K Sell
8,070
-2,185
-21% -$168K 0.1% 290
2023
Q2
$790K Buy
+10,255
New +$818K 0.14% 160
2023
Q1
Sell
-4,902
Closed -$421K 1417
2022
Q4
$421K Buy
4,902
+148
+3% +$11.7K 0.09% 383
2022
Q3
$293K Sell
4,754
-14,615
-75% -$922K 0.07% 520
2022
Q2
$1.2M Buy
19,369
+8,089
+72% +$501K 0.49% 17
2022
Q1
$671K Buy
11,280
+5,863
+108% +$375K 0.29% 85
2021
Q4
$393K Sell
5,417
-9,124
-63% -$628K 0.22% 118
2021
Q3
$1.02M Buy
+14,541
New +$1.02M 0.34% 51

Other funds holding GILD

XTX Topco's GILD Position: Q1 2026 in Review

XTX Topco opened a new position in Gilead Sciences (GILD) in Q1 2026: 60,352 shares worth $8.41M. The stake represents 0.15% of the portfolio and ranks #91 among its holdings. This is a return to the name: XTX Topco previously reported a position in GILD as recently as Q1 2025.

XTX Topco first reported a position in GILD in Q3 2021 and has held it in 13 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • XTX Topco held 60,352 shares of Gilead Sciences worth $8.41M as of Q1 2026.
  • Gilead Sciences was a new XTX Topco position in Q1 2026.
  • Gilead Sciences made up 0.15% of XTX Topco's portfolio in Q1 2026, its #91 holding.
  • XTX Topco first reported a position in Gilead Sciences in Q3 2021 and has held it in 13 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.